Compensation award — excluded from discretionary-purchase analysis.
Loading…
Insider tradesView the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership
Insider trade
Director purchased ~$960K of PFE shares in the open market
Traded Aug 5, 2026 · Filed Aug 5, 2026
- ~$960K
- Reported value · 38K sh @ $25.52
- 38K
- Holds after · shares reported
- +8.9%
- stock since the trade · S&P 500 -0.8%, $25.81 → $28.12 on Oct 1
Why it stands out
Bought on the open market with their own money
- Bought on the open market with their own money
- 3 different insiders at Pfizer bought within a month
- No other insider purchase at Pfizer in the past year
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Aug 5, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Aug 5, 2026
Director$500K–$1M3 insiders bought in 30d
Context
- Classification
open market purchase
Code P — open-market or private purchase
- Absolute commitment
~$960,369
Shares × reported transaction price
- Size band
$500K–$1M
- Rarity
Not enough history to judge
